SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:lup.lub.lu.se:e5fa13c1-fe9b-4605-a0e9-fe9926fcc8ab"
 

Search: onr:"swepub:oai:lup.lub.lu.se:e5fa13c1-fe9b-4605-a0e9-fe9926fcc8ab" > Succinate prodrugs ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Succinate prodrugs as treatment for acute metabolic crisis during fluoroacetate intoxication in the rat

Piel, Sarah (author)
The Children's Hospital of Philadelphia
Janowska, Joanna I. (author)
The Children's Hospital of Philadelphia
Ward, J. Laurenson (author)
The Children's Hospital of Philadelphia
show more...
McManus, Meagan J. (author)
The Children's Hospital of Philadelphia
Aronowitz, Danielle I. (author)
The Children's Hospital of Philadelphia
Janowski, Piotr K. (author)
The Children's Hospital of Philadelphia
Starr, Jonathan (author)
The Children's Hospital of Philadelphia
Hook, Jordan N. (author)
University of Iowa Carver College of Medicine
Hefti, Marco M. (author)
University of Iowa Carver College of Medicine
Clayman, Carly L. (author)
The Children's Hospital of Philadelphia
Elmér, Eskil (author)
Lund University,Lunds universitet,Klinisk neurofysiologi,Sektion IV,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Mitokondriell Medicin,Forskargrupper vid Lunds universitet,Clinical Neurophysiology,Section IV,Department of Clinical Sciences, Lund,Faculty of Medicine,Mitochondrial Medicine,Lund University Research Groups,Abliva AB
Hansson, Magnus J. (author)
Lund University,Lunds universitet,Klinisk neurofysiologi,Sektion IV,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Mitokondriell Medicin,Forskargrupper vid Lunds universitet,Clinical Neurophysiology,Section IV,Department of Clinical Sciences, Lund,Faculty of Medicine,Mitochondrial Medicine,Lund University Research Groups,Abliva AB
Jang, David H. (author)
University of Pennsylvania
Karlsson, Michael (author)
Copenhagen University Hospital
Ehinger, Johannes K. (author)
Lund University,Lunds universitet,Mitokondriell Medicin,Forskargrupper vid Lunds universitet,Mitochondrial Medicine,Lund University Research Groups
Kilbaugh, Todd J. (author)
The Children's Hospital of Philadelphia
show less...
 (creator_code:org_t)
2022-10-25
2023
English.
In: Molecular and Cellular Biochemistry. - : Springer Science and Business Media LLC. - 0300-8177 .- 1573-4919. ; 478:6, s. 1231-1244
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Sodium fluoroacetate (FA) is a metabolic poison that systemically inhibits the tricarboxylic acid (TCA) cycle, causing energy deficiency and ultimately multi-organ failure. It poses a significant threat to society because of its high toxicity, potential use as a chemical weapon and lack of effective antidotal therapy. In this study, we investigated cell-permeable succinate prodrugs as potential treatment for acute FA intoxication. We hypothesized that succinate prodrugs would bypass FA-induced mitochondrial dysfunction, provide metabolic support, and prevent metabolic crisis during acute FA intoxication. To test this hypothesis, rats were exposed to FA (0.75 mg/kg) and treated with the succinate prodrug candidate NV354. Treatment efficacy was evaluated based on cardiac and cerebral mitochondrial respiration, mitochondrial content, metabolic profiles and tissue pathology. In the heart, FA increased concentrations of the TCA metabolite citrate (+ 4.2-fold, p < 0.01) and lowered ATP levels (− 1.9-fold, p < 0.001), confirming the inhibition of the TCA cycle by FA. High-resolution respirometry of cardiac mitochondria further revealed an impairment of mitochondrial complex V (CV)-linked metabolism, as evident by a reduced phosphorylation system control ratio (− 41%, p < 0.05). The inhibition of CV-linked metabolism is a novel mechanism of FA cardiac toxicity, which has implications for drug development and which NV354 was unable to counteract at the given dose. In the brain, FA induced the accumulation of β-hydroxybutyrate (+ 1.4-fold, p < 0.05) and the reduction of mitochondrial complex I (CI)-linked oxidative phosphorylation (OXPHOSCI) (− 20%, p < 0.01), the latter of which was successfully alleviated by NV354. This promising effect of NV354 warrants further investigations to determine its potential neuroprotective effects.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Farmakologi och toxikologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Pharmacology and Toxicology (hsv//eng)

Keyword

Cell-permeable succinate
Emergency medicine
Fluoroacetate
Mitochondria
Toxicity

Publication and Content Type

art (subject category)
ref (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view